COR vs MCK
Cencora, Inc. (COR) and Mckesson Corp (MCK) are both filed with the SEC under Wholesale-Drugs, Proprietaries & Druggists' Sundries. MCK is 1.7× COR's size by market cap ($103.8B against $61.3B); COR trades at the higher fiscal-year P/E (40.4× against 23.2×); MCK reports the higher net margin (1.2% against 0.5%); MCK grew sales faster over three years (+13.4% against +10.4%); and over the past year MCK returned +31.7% against COR's +11.7%.
| COR | MCK | |
|---|---|---|
| Last close | $322.03 | $893.39 |
| Market cap | $61.3B | $103.8B |
| P/E (FY) | 40.4× | 23.2× |
| P/S | 0.2× | 0.3× |
| EV/EBITDA | 17.6× | 16.6× |
| Gross margin | 3.6% | 3.6% |
| Operating margin | 0.8% | 1.5% |
| Net margin | 0.5% | 1.2% |
| Return on equity | 144.3% | — |
| Sales growth (3y) | +10.4% | +13.4% |
| EPS growth (3y) | -0.3% | +15.3% |
| Dividend yield | 0.7% | 0.4% |
| 1-year return | +11.7% | +31.7% |
Screener snapshot — prices as of 2026-08-28. Each side's last close is the most recent session the snapshot holds for that company, which can be an earlier one, and its 1-year return is measured to that close. Market caps struck on 2026-08-27. Last close, market cap and the 1-year return are price figures; every other row is computed over the company's latest filed fiscal year, and the two differ: COR FY2025 (ended 2025-09-30); MCK FY2026 (ended 2026-03-31). A return on equity past ±100% — COR at 144.3% — divides earnings by an average filed equity base smaller in magnitude than the earnings themselves; the two columns are not on one scale. — not published for this company. A ratio goes unpublished for more than one reason: a component the calculation needs is not on file, the filing does not tag the line it is read from, or the calculation is not defined on the filed basis — EV/EBITDA is not printed on non-positive EBITDA, and return on equity is not computed on a zero or negative equity base.
Who holds them, and who has traded them
| COR | MCK | |
|---|---|---|
| Institutional holders (13F) | 1,423 | 2,018 |
| Insider buyers − sellers (180d) | +2 | -5 |
| Congressional trades disclosed (180d) | 6 | 4 |
| Executive-branch officials on file — trades disclosed (180d) | 4 | 8 |
Counts only. The congressional figures count transactions dated in the trailing 180 days and disclosed in STOCK Act periodic transaction reports; amounts are filed as ranges and are never summed. The executive-branch figures count the same window of transactions, and they are scoped to one roster. The officials OGE posts for direct download. Insider buyers − sellers counts distinct people filing open-market Form 4 purchases minus distinct people filing open-market sales over the trailing 180 days, capped at ±5.
COR vs MCK: common questions
- Is COR bigger than MCK?
- MCK carries the larger market cap — $103.8B against $61.3B, both struck on 2026-08-27.
- Which trades at a higher P/E, COR or MCK?
- COR, at a fiscal-year 40.4× against 23.2× for MCK. Both are price ÷ latest full-year diluted earnings per share, not a trailing-twelve-month P/E.
- How have COR and MCK performed over the past year?
- MCK returned +31.7% and COR +11.7%, measured on the trailing calendar year to the last close.
- How many institutions hold COR and MCK?
- 1,423 13F filers report a position in COR and 2,018 in MCK, on the latest quarter in the panel.
- Are COR and MCK in the same industry?
- Both are filed with the SEC under Wholesale-Drugs, Proprietaries & Druggists' Sundries, which is the classification this pairing is built on.
COR overview → · MCK overview → · COR institutional ownership → · MCK institutional ownership → · Congress and COR → · Congress and MCK → · Executive branch and COR → · Executive branch and MCK →
More in Wholesale-Drugs, Proprietaries & Druggists' Sundries: CAH vs COR · CAH vs MCK
Stock comparisons lists every pair this site publishes.
Source: SPZCO — https://spzco.com/vs/cor-vs-mck